Targeting the endocannabinoid system to reduce nociception
Pain of various etiologies (e.g., visceral, inflammatory) can be a debilitating disorder that presents a problem of clinical relevance. While it is known that ∆9-tetrahydrocannabinol (THC) the primary psychoactive constituent found in marijuana produces analgesia in various rodent models of pain, it...
Main Author: | Booker, Lamont |
---|---|
Format: | Others |
Published: |
VCU Scholars Compass
2011
|
Subjects: | |
Online Access: | http://scholarscompass.vcu.edu/etd/2419 http://scholarscompass.vcu.edu/cgi/viewcontent.cgi?article=3418&context=etd |
Similar Items
-
Elevating Endogenous Cannabinoids Reduces Opioid Withdrawal in Mice
by: Ramesh, Divya
Published: (2012) -
The Endocannabinoid System as a Potential Therapeutic Target for Pain Modulation
by: Ahmet Ulugöl
Published: (2014-06-01) -
Targeting the Endocannabinoid System to Reduce Inflammatory Pain
by: Ghosh, Sudeshna
Published: (2012) -
A Guide to Targeting the Endocannabinoid System in Drug Design
by: Adam Stasiulewicz, et al.
Published: (2020-04-01) -
The Role of MAGL Inhibition in Nicotine Withdrawal and Reward
by: Muldoon, Pretal
Published: (2012)